ISLAMABAD: The Drug Regulatory Authority of Pakistan (Drap) has directed a pharmaceutical company to recall a syrup, which is given to children to treat fever, from the market and has advised the health professionals not to prescribe it.

The direction has been giving after getting a report from the federal government analyst Central Drugs Laboratory (CDL), Karachi, that the medicine — Barpon 100mg/5ml — has been found substandard.

However, representative of the manufacturing company, JASM Pharmaceutical (Pvt) Ltd, Risalpur, has announced the decision to challenge the Drap move, claiming that the syrup could not be declared substandard as company also got it tested before dispatching it to market.

The Drap document, seen by Dawn, said the batch (No. 202), having manufacturing date of July 2023 and expiry date of June 2025, has been found substandard. It stated that Barpon infusion contains ibup­rofen, a medicine used to treat mild to moderate pain and fever (high temperature).

Company to challenge decision, claims product tested before dispatch

The administration of substandard products may lead to complications, as well as an increased risk of failure of therapy. The age-profile of patients is important and young patients especially are at risk, according to the document.

“The manufacturer has been directed to immediately recall the defective batch of product from the market. All pharmacists and chemists working at distributions and pharmacies are hereby advised to immediately check their stocks and stop supplying this batch of product. The remaining stock should be quarantined and returned to the supplier/company,” it stated.

However, JASM’s Director Mohammad Khalid told Dawn that the company was ISO-9001 certified (for having quality management system) and it tests raw material and also finished products.

“We give medicines of our company to our own children. We will challenge Drap’s decision as we tested both the raw material and finished product from a lab,” Mr Khalid said.

Published in Dawn, March 18th, 2024

Opinion

Editorial

Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...
Islamabad protest
Updated 20 Nov, 2024

Islamabad protest

As Nov 24 draws nearer, both the PTI and the Islamabad administration must remain wary and keep within the limits of reason and the law.
PIA uncertainty
20 Nov, 2024

PIA uncertainty

THE failed attempt to privatise the national flag carrier late last month has led to a fierce debate around the...
T20 disappointment
20 Nov, 2024

T20 disappointment

AFTER experiencing the historic high of the One-day International series triumph against Australia, Pakistan came...